[Physiopathology of scleroderma]
- PMID: 8363310
[Physiopathology of scleroderma]
Abstract
Scleroderma (systemic sclerosis) is a connective tissue disease characterized by an excessive accumulation of collage in the main body organs. The subsequent progressive fibrosis may result in severe functional impairment of the tissue(s) involved. In this paper, recent advances in the understanding of the disease are reviewed. Particular emphasis is placed on the role played by vascular lesions, inflammatory cell infiltrates, autoimmunity and possibly abnormal secretion of cytokines in the disturbance of connective tissue production. A better knowledge of the pathophysiological process involved in scleroma might lead to the development of new therapeutic approaches.
Similar articles
-
Immunological basis of systemic sclerosis.Rheumatology (Oxford). 2006 Oct;45 Suppl 3:iii23-5. doi: 10.1093/rheumatology/kel285. Rheumatology (Oxford). 2006. PMID: 16987826 Review.
-
Pathophysiology of scleroderma: an update.J Eur Acad Dermatol Venereol. 1998 Jul;11(1):1-8. J Eur Acad Dermatol Venereol. 1998. PMID: 9731958 Review.
-
Immunopathogenesis of scleroderma--evolving concepts.Mt Sinai J Med. 2001 Sep-Oct;68(4-5):233-42. Mt Sinai J Med. 2001. PMID: 11514910 Review.
-
[Immunopathological disturbances in systemic sclerosis].Pol Merkur Lekarski. 2005 Dec;19(114):800-3. Pol Merkur Lekarski. 2005. PMID: 16521427 Review. Polish.
-
Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets.Autoimmun Rev. 2007 Dec;7(2):121-6. doi: 10.1016/j.autrev.2007.02.020. Epub 2007 Mar 28. Autoimmun Rev. 2007. PMID: 18035321 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical